Literature DB >> 30720170

MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.

Y-H Liu1, J-L Liu, Z Wang, X-H Zhu, X-B Chen, M-Q Wang.   

Abstract

OBJECTIVE: Mounting evidence has suggested that microRNAs (miRNAs) play crucial roles in the progression of nasopharyngeal carcinoma (NPC). However, the molecular mechanism remains not fully understood. We aimed to examine the expression and biological function of miR-122-5p in NPC.
MATERIALS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction was conducted to examine the expression of miR-122-5p. Cell Counting Kit-8 assay, colony formation assay, wound healing assay and transwell assay were performed to measure cell proliferation, colony formation, migration and invasion. Luciferase reporter assay and Western blot assay were used to confirm the target gene of miR-122-5p.
RESULTS: The results showed that miR-122-5p was significantly downregulated in NPC cell lines. Additionally, it was demonstrated that special AT-rich sequence-binding protein 1 (SATB1) was targeted by miR-122-5p. Furthermore, our results revealed that miR-122-5p inhibits cell proliferation, colony formation, cell migration and cell invasion by targeting SATB1.
CONCLUSIONS: Our data suggested that miR-122-5p functions as a tumor suppressor and may be a therapeutic target for NPC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720170     DOI: 10.26355/eurrev_201901_16876

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  miR-122-5p Mediates Fluoride-Induced Osteoblast Activation by Targeting CDK4.

Authors:  Chen Li; Yu Qin; Ting Ouyang; Maolin Yao; Aihua Zhang; Peng Luo; Xueli Pan
Journal:  Biol Trace Elem Res       Date:  2020-06-22       Impact factor: 3.738

2.  MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2.

Authors:  Hongwei Fan; Rong Ai; Suen Mu; Xuemin Niu; Zhengrong Guo; Lin Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.

Authors:  Zhengbin Zhao; Jing Gao; Shuangsheng Huang
Journal:  Dig Dis Sci       Date:  2021-03-18       Impact factor: 3.199

4.  Combined Detection of Serum MiR-221-3p and MiR-122-5p Expression in Diagnosis and Prognosis of Gastric Cancer.

Authors:  Yan Zhang; Huifeng Huang; Yun Zhang; Nansheng Liao
Journal:  J Gastric Cancer       Date:  2019-08-30       Impact factor: 3.720

5.  Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p.

Authors:  Wenzhe Yin; Jun Xu; Chao Li; Xiankui Dai; Tong Wu; Jifeng Wen
Journal:  Onco Targets Ther       Date:  2020-05-01       Impact factor: 4.147

6.  Long non‑coding RNA ZEB2‑AS1 affects cell proliferation and apoptosis via the miR‑122‑5p/PLK1 axis in acute myeloid leukemia.

Authors:  Jianmin Guan; Ping Liu; Aixia Wang; Bo Wang
Journal:  Int J Mol Med       Date:  2020-07-23       Impact factor: 4.101

7.  miRNA-122-5p stimulates the proliferation and DNA synthesis and inhibits the early apoptosis of human spermatogonial stem cells by targeting CBL and competing with lncRNA CASC7.

Authors:  Fan Zhou; Wei Chen; Yinghong Cui; Bang Liu; Qingqing Yuan; Zheng Li; Zuping He
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

8.  miR-122-5p regulates the tight junction of the blood-testis barrier of mice via occludin : miR-122-5p can regulate the tight junction.

Authors:  Limin Liu; Maoying Zhu; Xiaoli Liu; Lumin Fei; Jianyun Shen; Deyu Chen
Journal:  Basic Clin Androl       Date:  2021-04-08

Review 9.  MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology.

Authors:  Warren B Nothnick
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

10.  The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.

Authors:  Paweł Robak; Izabela Dróżdż; Dariusz Jarych; Damian Mikulski; Edyta Węgłowska; Monika Siemieniuk-Ryś; Małgorzata Misiewicz; Konrad Stawiski; Wojciech Fendler; Janusz Szemraj; Piotr Smolewski; Tadeusz Robak
Journal:  Cancers (Basel)       Date:  2020-09-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.